1. Home
  2. ARLP vs MLYS Comparison

ARLP vs MLYS Comparison

Compare ARLP & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alliance Resource Partners L.P.

ARLP

Alliance Resource Partners L.P.

HOLD

Current Price

$23.67

Market Cap

3.3B

Sector

Energy

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$36.64

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARLP
MLYS
Founded
1971
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.1B
IPO Year
1999
2023

Fundamental Metrics

Financial Performance
Metric
ARLP
MLYS
Price
$23.67
$36.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$29.50
$46.40
AVG Volume (30 Days)
232.1K
1.7M
Earning Date
02-02-2026
11-10-2025
Dividend Yield
9.95%
N/A
EPS Growth
N/A
N/A
EPS
1.89
N/A
Revenue
$2,249,390,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.41
N/A
P/E Ratio
$12.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.20
$8.24
52 Week High
$30.56
$47.65

Technical Indicators

Market Signals
Indicator
ARLP
MLYS
Relative Strength Index (RSI) 42.19 38.36
Support Level $24.02 $35.77
Resistance Level $24.60 $39.15
Average True Range (ATR) 0.50 1.91
MACD 0.01 -0.57
Stochastic Oscillator 16.36 7.89

Price Performance

Historical Comparison
ARLP
MLYS

About ARLP Alliance Resource Partners L.P.

Alliance Resource Partners LP operates as a coal mining company based in the United States. It has four segments: Illinois Basin, Appalachia, Oil & Gas Royalties and Coal Royalties. The Illinois Basin comprises underground mining complexes in Illinois, Indiana, Kentucky, Maryland and West Virginia. The Appalachia segment comprises the Mettiki mining complex, the Tunnel Ridge mining complex and the MC Mining complex. The Oil & Gas Royalties has oil & gas mineral interests held by AR Midland and AllDale I & II and includes Alliance Minerals' equity interests in both AllDale III and Cavalier Minerals. The Coal Royalties has included coal mineral reserves and resources owned or leased by Alliance Resource Properties.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: